Population Pharmacokinetic Analyses for BC-3781 Using Phase 2 Data from Patients with Acute Bacterial Skin and Skin Structure Infections

類似資料

• Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
  著者:: Prince, W. T., 等
  出版事項: (2013)
• Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
  著者:: Sader, Helio S., 等
  出版事項: (2012)
• Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010
  著者:: Paukner, Susanne, 等
  出版事項: (2013)
• Disk Diffusion and MIC Quality Control Ranges for BC-3205 and BC-3781, Two Novel Pleuromutilin Antibiotics
  著者:: Ross, James E., 等
  出版事項: (2012)
• Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data
  著者:: Lakota, Elizabeth A., 等
  出版事項: (2020)